Lumos Pharma Inc. buy melinda
Start price
10.09.17
/
50%
€147.67
Target price
11.09.17
€194.83
Performance (%)
-10.78%
End price
11.09.17
€131.74
Summary
This prediction ended on 11.09.17 with a price of €131.74. The price of Lumos Pharma Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.78%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Lumos Pharma Inc. | -7.692% | -7.692% | -34.940% | -74.588% |
iShares Core DAX® | -0.683% | 1.890% | 15.367% | 17.155% |
iShares Nasdaq 100 | 0.335% | 4.631% | 29.818% | 56.187% |
iShares Nikkei 225® | -1.486% | -2.361% | 7.668% | 3.633% |
iShares S&P 500 | -0.523% | 2.324% | 25.460% | 46.452% |
Comments by melinda for this prediction
In the thread NewLink Genetics Corp diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Lumos Pharma Inc.
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€95.14
13.10.17
13.10.17
€129.89
27.12.17
27.12.17
-30.46%
27.12.17
27.12.17
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€105.48
13.10.17
13.10.17
€144.00
27.12.17
27.12.17
-30.46%
27.12.17
27.12.17
Lumos Pharma Inc.
Start price
Target price
Perf. (%)
€52.12
14.06.17
14.06.17
€121.77
08.09.17
08.09.17
151.87%
08.09.17
08.09.17